DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) today announced that Dr. Mark Pykett, President and CEO will participate at the Biotech Showcase Conference. Dr. Pykett will provide an update of the Company and its development programs on January 9, 2012 at 1:30 PM EST (10:30 AM PST) in San Francisco, CA.
Investors and the public are invited to listen to a live webcast of Dr. Pykett’s presentation at http://www.media-server.com/m/p/ern2i7ej. Following the conference, the webcast will be archived for approximately 30 days.
Investors and the public are invited to listen to a live webcast of Dr. Pykett’s presentation at http://www.media-server.com/m/p/ern2i7ej. Following the conference, the webcast will be archived for approximately 30 days.
